Bionano genomics announces uk footprint expansion with adoption of its saphyr® system for optical genome mapping in two genetic laboratory hubs within the united kingdom's national health service

San diego, feb. 02, 2022 (globe newswire) -- bionano genomics, inc. (bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™, the leading software solutions for visualization, interpretation and reporting of genomic data, today announced the adoption of its saphyr system by two genetics laboratory hubs (glh) within the united kingdom's (uk) national health service (nhs). the newcastle upon tyne hospitals nhs foundation trust and the birmingham women's and children nhs foundation trust intends to utilize the system to evaluate ogm against traditional cytogenetic methods.
BNGO Ratings Summary
BNGO Quant Ranking